Form 4 for NHC NATIONAL HEALTHCARE CORP
Accepted 2022-05-06 00:00:00 ET · period of report 2022-05-05 · accession 0001437749-22-011327 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-05-06 | 2022-05-05 | NHC | HASSAN EMIL E | Dir | M - OptEx | $72.94 | +7,500 | 78.6K | +11% | +$547.0K |
| D | 2022-05-06 | 2022-05-05 | NHC | HASSAN EMIL E | Dir | M - OptEx | $0.00 | -7,500 | 0 | -100% | $0 |
| D | 2022-05-06 | 2022-05-05 | NHC | HASSAN EMIL E | Dir | A - Grant | $0.00 | +7,500 | 7,500 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Shares of Common Stock | 2022-05-05 | M | A | 7,500 | $72.94 | 78,595 | D | — | — | (F1) These stock options were granted pursuant to the 2010 Omnibus Equity Incentive Plan on May 9, 2017. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). |
| 2 | Derivative | Option to Purchase Common Stock | 2022-05-05 | M | D | 7,500 | $0.00 | 0 | D | $72.94 · 2017-05-09 to 2022-05-08 | 7,500 Common Stock | |
| 3 | Derivative | Option to Purchase Common Stock [2022 Grant] | 2022-05-05 | A | A | 7,500 | $0.00 | 7,500 | D | $69.19 · 2023-05-05 to 2027-05-04 | 7,500 Common Stock | (F2) These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on May 5, 2022. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). |